findmyKOL
Clinical trialNCT02017509CompletedObservational

Immunoscore in Rectal Cancer

SponsorProvidence Health & ServicesEnrollment3Cancer of the RectumNeoplasms, RectalRectal AdenocarcinomaRectal CancerRectal Tumors
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Marka Crittenden, MD, PhD

    Earle A. Chiles Research Institute at Providence Health & Services

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Oregon Health & Science University

    Portland, Oregon, United States

  • Providence Health & Services

    Portland, Oregon, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
24 Jan 2014
Primary completion
17 Jul 2018
Completion
17 Jul 2018
Last update posted
29 Aug 2018
Registered enrollment
3
Registry id
NCT02017509

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.